dr Tim L Jansen, MD PhD - Dept Rheumatology/ VieCuri MC  - rheumatologist

dr Tim L Jansen

MD PhD

Dept Rheumatology/ VieCuri MC

rheumatologist

Venlo | Netherlands

dr Tim L Jansen, MD PhD - Dept Rheumatology/ VieCuri MC  - rheumatologist

dr Tim L Jansen

MD PhD

Introduction

Primary Affiliation: Dept Rheumatology/ VieCuri MC - Venlo , Netherlands

Publications

68Publications

2425Reads

121Profile Views

421PubMed Central Citations

Vasodilator function worsens after cessation of tumour necrosis factor inhibitor therapy in patients with rheumatoid arthritis only if a flare occurs.

Clin Rheumatol 2018 Apr 7;37(4):909-916. Epub 2018 Jan 7.

VieCuri Medical Centre, Venlo, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10067-017-3961-6DOI Listing
April 2018
9 Reads
1.774 Impact Factor

The American College of Physicians and the 2017 guideline for the management of acute and recurrent gout: treat to avoiding symptoms versus treat to target.

Clin Rheumatol 2017 Nov 17;36(11):2399-2402. Epub 2017 Sep 17.

Department of Rheumatology, VieCuri Medical Center, Venlo, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10067-017-3840-1DOI Listing
November 2017
7 Reads
1 Citation
1.774 Impact Factor

Quality of care in gout: a clinical audit on treating to the target with urate lowering therapy in real-world gout patients.

Rheumatol Int 2017 Sep 26;37(9):1435-1440. Epub 2017 Jul 26.

Department of Psychology, Health and Technology, Arthritis Center Twente, University of Twente, PO BOX 217, 7500 AE, Enschede, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00296-017-3777-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5570767PMC
September 2017
29 Reads
1.630 Impact Factor

Measuring Disease Exacerbation and Flares in Rheumatoid Arthritis: Comparison of Commonly Used Disease Activity Indices and Individual Measures.

J Rheumatol 2017 08 15;44(8):1118-1124. Epub 2017 May 15.

From the Arthritis Center Twente, Department of Psychology, Health and Technology, University of Twente; Arthritis Center Twente, Department of Rheumatology and Clinical Immunology, Medical Spectrum Twente, Enschede; Department of Rheumatology, VU University Medical Center and Reade Medical Center, Amsterdam; Department of Rheumatology, University Medical Center Utrecht, Utrecht; Department of Rheumatology, Rijnstate Medical Center, Arnhem; Department of Rheumatology, Viecuri Medical Center, Venlo, the Netherlands; Department of Rheumatology, University Hospital Leuven, Leuven, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.160915DOI Listing
August 2017
68 Reads
3.190 Impact Factor

Performance of the 2015 ACR-EULAR classification criteria for gout in a primary care population presenting with monoarthritis.

Rheumatology (Oxford) 2017 08;56(8):1335-1341

Department of Medicine, University of Otago, Wellington, New Zealand.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/rheumatology/kex164DOI Listing
August 2017
13 Reads
4.475 Impact Factor

Effectiveness of Tumor Necrosis Factor Inhibitors in Combination with Various csDMARD in the Treatment of Rheumatoid Arthritis: Data from the DREAM Registry.

J Rheumatol 2016 10 1;43(10):1787-1794. Epub 2016 Aug 1.

From the Department of IQ Healthcare, the Department of Health Evidence, the Department of Rheumatic Diseases, Radboud University Medical Center, Nijmegen; Rheumatology, Ziekenhuis Gelderse Vallei, Ede; Rheumatology, Rijnstate, Arnhem; Rheumatology, Medical Centre Leeuwarden, Leeuwarden; Arthritis Centre Twente, Rheumatology and Clinical Immunology, Medical Spectrum Twente, Enschede, the Netherlands.S.H. Manders, MSc, Department of IQ Healthcare, Radboud University Medical Center; W. Kievit, PhD, Department of Health Evidence, Radboud University Medical Center; T.L. Jansen, PhD, Department of Rheumatic Diseases, Radboud University Medical Center; J.N. Stolk, PhD, Rheumatology, Ziekenhuis Gelderse Vallei; H. Visser, PhD, Rheumatology, Rijnstate; A.M. Schilder, MD, Rheumatology, Medical Centre Leeuwarden; H.E. Vonkeman, PhD, Arthritis Centre Twente, Rheumatology and Clinical Immunology, Medical Spectrum Twente; E. Adang, PhD, Department of Health Evidence, Radboud University Medical Center; M.A. van de Laar, Professor, Arthritis Centre Twente, Rheumatology and Clinical Immunology, Medical Spectrum Twente; P.L. van Riel, Professor, Department of IQ Healthcare, Radboud University Medical Center.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.151014DOI Listing
October 2016
37 Reads
1 Citation
3.190 Impact Factor

Discrepancies in how the impact of gout is assessed in outcomes research compared to how health professionals view the impact of gout, using the lens of the International Classification of Functioning, Health and Disability (ICF).

Clin Rheumatol 2016 Sep 14;35(9):2259-68. Epub 2016 Jun 14.

Department of Medicine, University of Otago Wellington, PO Box 7343, Wellington, New Zealand.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10067-016-3325-7DOI Listing
September 2016
14 Reads
1.774 Impact Factor

Valuable verities on vitamin D.

Int J Rheum Dis 2016 Apr;19(4):329-31

Department of Psychology, Health and Technology, Faculty of Behavioural Sciences, University of Twente, Enschede, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/1756-185X.12894DOI Listing
April 2016
9 Reads
1.771 Impact Factor

Soluble uric acid primes TLR-induced proinflammatory cytokine production by human primary cells via inhibition of IL-1Ra.

Ann Rheum Dis 2016 Apr 3;75(4):755-62. Epub 2015 Feb 3.

Department of Internal Medicine, Radboud University Medical Center, Nijmegen, The Netherlands Radboud Institute of Molecular Life Science (RIMLS), Radboud University Medical Center, Nijmegen, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/annrheumdis-2014-206564DOI Listing
April 2016
24 Reads
17 Citations
10.380 Impact Factor

Suppression of monosodium urate crystal-induced cytokine production by butyrate is mediated by the inhibition of class I histone deacetylases.

Ann Rheum Dis 2016 Mar 14;75(3):593-600. Epub 2015 Jan 14.

Department of Internal Medicine, Radboud University Medical Center, Nijmegen, The Netherlands Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/annrheumdis-2014-206258DOI Listing
March 2016
35 Reads
9 Citations
10.380 Impact Factor

Diagnostic Arthrocentesis for Suspicion of Gout Is Safe and Well Tolerated.

J Rheumatol 2016 Jan 1;43(1):150-3. Epub 2015 Dec 1.

From the University of Otago, Wellington; University of Auckland, Auckland; Department of Medicine, University of Otago Christchurch, Christchurch, New Zealand; Radboud University Medical Centre, Nijmegen; Amsterdam Rheumatology Immunology Center (ARC), Department of Rheumatology, Westfries Gasthuis, Hoorn; Rijnstate Hospital, Arnhem, the Netherlands; Boston University School of Medicine, Boston, Massachusetts; University of Pennsylvania, Philadelphia, Pennsylvania, USA; Division of Rheumatology, Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand; Servicio de Reumatología, Hospital General de México, México City, México; Nasonova Research Institute of Rheumatology of Russia, Moscow, Russia; School of Medicine and Medical Science, University College Dublin; Mater Misericordiae University Hospital, Dublin, Ireland; Rheumatology Division, Hospital Universitario Cruces and BioCruces Health Research Institute, Vizcaya; Department Reumatologia, Hospital General Universitario de Elda, Alicante, Spain; Université Paris Diderot, Sorbonne Paris Cité, UFR de Médecine; Institut national de la santé et de la recherche médicale (INSERM), UMR 1132, Hôpital Lariboisière; Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Lariboisière, Service de Rhumatologie, Centre Viggo Petersen, Pôle Appareil Locomoteur, Paris, France; Epidemiology Unit, Italian Society for Rheumatology (SIR), Milan; Division of Rheumatology, University and IRCCS Policlinico S. Matteo Foundation, Pavia; Research Laboratory and Academic Division of Clinical Rheumatology, Department of Internal Medicine, University of Genoa, Genoa, Italy; Division of Rheumatology and Immunology, Taichung Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation; Taichung Veterans' General Hospital; School of Medicine, China Medical University; Department of Internal Medicine, China Medical University Hospital, Taichung, Taiwan; Division of Rheumatology, Department of In

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.150684DOI Listing
January 2016
153 Reads
3 Citations
3.190 Impact Factor

Imaging modalities for the classification of gout: systematic literature review and meta-analysis.

Ann Rheum Dis 2015 Oct 10;74(10):1868-74. Epub 2014 Jun 10.

Department of Medicine, University of Auckland, Auckland, New Zealand.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/annrheumdis-2014-205431DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4869978PMC
October 2015
28 Reads
18 Citations
10.380 Impact Factor

Gout: cartoonized and bagatellized and still left untreated. Time to change.

Authors:
Tim L Jansen

Clin Rheumatol 2015 Jul 7;34(7):1317-9. Epub 2015 Jun 7.

Department of Rheumatology VieCuri MC, Venlo, The Netherlands,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10067-015-2986-yDOI Listing
July 2015
8 Reads
1.774 Impact Factor

Rational pharmacotherapy (RPT) in goutology: Define the serum uric acid target & treat-to-target patient cohort and review on urate lowering therapy (ULT) applying synthetic drugs.

Authors:
Tim L Jansen

Joint Bone Spine 2015 Jul 22;82(4):225-9. Epub 2015 Jun 22.

RadboudUMC, Rheumatology, Nijmegen, The Netherlands. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jbspin.2014.02.015DOI Listing
July 2015
8 Reads
2.901 Impact Factor

Cost-effectiveness of abatacept, rituximab, and TNFi treatment after previous failure with TNFi treatment in rheumatoid arthritis: a pragmatic multi-centre randomised trial.

Arthritis Res Ther 2015 May 22;17:134. Epub 2015 May 22.

Department of IQ Healthcare, Radboud Institute for Health Sciences, Radboud University Medical Centre, Postbus 9101, Geert Grooteplein Noord 21 (Route 114), 6500 HB, Nijmegen, Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13075-015-0630-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4489004PMC
May 2015
34 Reads
2 Citations
3.753 Impact Factor

Personalizing treatment targets in rheumatoid arthritis by using a simple prediction model.

J Rheumatol 2015 Mar 15;42(3):398-404. Epub 2015 Jan 15.

From the Department of Rheumatology, Radboud University Medical Centre, and the Department of Rheumatology, Sint Maartenskliniek, Nijmegen, the Netherlands.Y.M.R. de Punder, MD; T.L.Th. A. Jansen, MD, PhD; A.E. van Ede, MD, PhD; P.L.C.M. van Riel, MD, PhD, Professor of Rheumatology; J. Fransen, PhD, Department of Rheumatology, Radboud University Medical Centre; A.A. den Broeder, MD, PhD, Department of Rheumatology, Sint Maartenskliniek.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.140085DOI Listing
March 2015
27 Reads
2 Citations
3.190 Impact Factor

Treat to target in gout by combining two modes of action.

Authors:
Tim L Jansen

Rheumatology (Oxford) 2014 Dec 23;53(12):2131-3. Epub 2014 Apr 23.

Department of Rheumatology, Radboud University Medical Center, Nijmegen, The Netherlands

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/rheumatology/keu043DOI Listing
December 2014
15 Reads
1 Citation
4.475 Impact Factor

Improving cardiovascular and renal outcomes in gout: what should we target?

Nat Rev Rheumatol 2014 Nov 19;10(11):654-61. Epub 2014 Aug 19.

Hôpital Lariboisière, Fédération de Rhumatologie, Centre Viggo Petersen 2, rue Ambroise Parè 75475 Cedex 10, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrrheum.2014.124DOI Listing
November 2014
75 Reads
26 Citations
9.850 Impact Factor

New gout test: enhanced ex vivo cytokine production from PBMCS in common gout patients and a gout patient with Kearns-Sayre syndrome.

Clin Rheumatol 2014 Sep 24;33(9):1341-6. Epub 2014 Apr 24.

Department of Rheumatology, Radboud University Medical Centre, Geert Grooteplein Noord 8, 6525 GA, Nijmegen, The Netherlands,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10067-014-2620-4DOI Listing
September 2014
21 Reads
1 Citation
1.774 Impact Factor

Practical eminence and experience-based recommendations for use of TNF-α inhibitors in sarcoidosis.

Sarcoidosis Vasc Diffuse Lung Dis 2014 Jul 8;31(2):91-107. Epub 2014 Jul 8.

Department of interstitial lung diseases, Hospital Gelderse Vallei Ede Maastricht, University, Faculty of Health, Medicine and Life Sciences, Department of Toxicology.

View Article

Download full-text PDF

Source
July 2014
29 Reads
6 Citations
1.744 Impact Factor

Association of the TNF-α G-308A polymorphism with TNF-inhibitor response in sarcoidosis.

Eur Respir J 2014 Jun 20;43(6):1730-9. Epub 2014 Feb 20.

Dept of Interstitial Lung Diseases, Gelderse Vallei Hospital, Ede, The Netherlands Dept of Toxicology, Maastricht University, Maastricht, The Netherlands

View Article

Download full-text PDF

Source
http://erj.ersjournals.com/cgi/doi/10.1183/09031936.00169413
Publisher Site
http://dx.doi.org/10.1183/09031936.00169413DOI Listing
June 2014
14 Reads
7 Citations
7.640 Impact Factor

Pulmonology meets rheumatology in sarcoidosis: a review on the therapeutic approach.

Curr Opin Rheumatol 2014 May;26(3):276-84

aDepartment of Toxicology, Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht binterstitial lung diseases care team (ild care team), Department of Respiratory Medicine, Hospital Gelderse Vallei, Ede cDepartment of Rheumatology, University Medical Centre St Radboud, Nijmegen, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/BOR.0000000000000052DOI Listing
May 2014
12 Reads
2 Citations
4.890 Impact Factor

New classification criteria for gout: a framework for progress.

Rheumatology (Oxford) 2013 Oct 22;52(10):1748-53. Epub 2013 Apr 22.

Department of Medicine, Faculty of Medical and Health Sciences, University of Auckland, 85 Park Road, Grafton, Auckland, New Zealand.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/rheumatology/ket154DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4047282PMC
October 2013
11 Reads
14 Citations
4.475 Impact Factor

[The multidisciplinary practice guideline "The responsible use of biologicals"].

Ned Tijdschr Geneeskd 2011 ;155(30-31):A3114

Universitair Medisch Centrum Utrecht, afd. Reumatologie & Klinische Immunologie, Utrecht, the Netherlands.

View Article

Download full-text PDF

Source
July 2013
9 Reads

Rheumatology meets radiology in the hot soup of Gutta.

Authors:
Tim L Jansen

Arthritis Res Ther 2012 Dec 19;14(6):126. Epub 2012 Dec 19.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/ar4068DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3674593PMC
December 2012
7 Reads
3.753 Impact Factor

Gout: why is this curable disease so seldom cured?

Ann Rheum Dis 2012 Nov 3;71(11):1765-70. Epub 2012 Aug 3.

Department of Rheumatology, City Hospital, Nottingham, UK.

View Article

Download full-text PDF

Source
http://ard.bmj.com/content/72/5/e5.full.pdf
Web Search
http://ard.bmj.com/content/early/2013/01/16/annrheumdis-2012
Web Search
http://ard.bmj.com/cgi/doi/10.1136/annrheumdis-2012-201687
Publisher Site
http://dx.doi.org/10.1136/annrheumdis-2012-201687DOI Listing
November 2012
63 Reads
45 Citations
10.380 Impact Factor

Rheumatology meets hepatology in 2012: a clinician's guideline for TNF inhibitors in hepatitis B/C virus carriers.

Expert Opin Biol Ther 2012 Apr;12(4):391-3

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14712598.2012.666521DOI Listing
April 2012
6 Reads
1 Citation
3.743 Impact Factor

Therapeutic consequences of crystals in the synovial fluid: a review for clinicians.

Clin Exp Rheumatol 2011 Nov-Dec;29(6):1032-9. Epub 2011 Dec 22.

Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands.

View Article

Download full-text PDF

Source
March 2012
9 Reads
1 Citation
2.724 Impact Factor

Effectiveness of a third tumor necrosis factor-α-blocking agent compared with rituximab after failure of 2 TNF-blocking agents in rheumatoid arthritis.

J Rheumatol 2011 Nov 1;38(11):2355-61. Epub 2011 Sep 1.

Department of Rheumatology, Radboud University Nijmegen Medical Centre, HB Nijmegen, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.101324DOI Listing
November 2011
26 Reads
5 Citations
3.190 Impact Factor

The potential risk of infections during (prolonged) rituximab therapy in rheumatoid arthritis.

Expert Opin Drug Saf 2011 Sep 15;10(5):715-26. Epub 2011 Mar 15.

Medical Centre Leeuwarden, Clinical Pharmacy & Pharmacology, PO Box 888, Leeuwarden, 8901BR, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14740338.2011.562188DOI Listing
September 2011
9 Reads
5 Citations
2.911 Impact Factor

Serum MMP-3 level as a biomarker for monitoring and predicting response to etanercept treatment in ankylosing spondylitis.

J Rheumatol 2011 Aug 1;38(8):1644-50. Epub 2011 Jun 1.

Department of Rheumatology and Clinical Immunology, University Medical Center Groningen, University of Groningen, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.101128DOI Listing
August 2011
26 Reads
8 Citations
3.190 Impact Factor

Rituximab in cryoglobulinaemic vasculitis, evidence for its effectivity: a case report and review of literature.

Clin Rheumatol 2011 Feb 31;30(2):293-300. Epub 2010 Oct 31.

Department of Rheumatology, Medical Centre Leeuwarden, Leeuwarden, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10067-010-1612-2DOI Listing
February 2011
26 Reads
5 Citations
1.774 Impact Factor

New advances in the treatment of gout: review of pegloticase.

Ther Clin Risk Manag 2010 Oct 27;6:543-50. Epub 2010 Oct 27.

Clinical Pharmacy, Atrium Medisch Centrum Parkstad, Heerlen, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/TCRM.S6043DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2988614PMC
October 2010
20 Reads
5 Citations
1.343 Impact Factor

When rheumatology meets hepatology: are anti-TNFs safe in hepatitis B virus carriers?

Authors:
Tim L Jansen

Arthritis Res Ther 2010 21;12(1):103. Epub 2010 Jan 21.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/ar2899DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2875626PMC
August 2010
7 Reads
2 Citations
3.753 Impact Factor

International position paper on febuxostat.

Clin Rheumatol 2010 Aug 17;29(8):835-40. Epub 2010 Apr 17.

Department of Rheumatology, Medisch Centrum Leeuwarden, Leeuwarden, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10067-010-1457-8DOI Listing
August 2010
70 Reads
10 Citations
1.774 Impact Factor

[Practice guideline 'Diagnosis and treatment of rheumatoid arthritis'].

Ned Tijdschr Geneeskd 2009 ;153:A944

Universitair Medisch Centrum St Radboud, afdeling Reumatologie, Nijmegen, The Netherlands.

View Article

Download full-text PDF

Source
February 2010
13 Reads

Management of hyperuricemia in gout: focus on febuxostat.

Clin Interv Aging 2010 Feb 2;5:7-18. Epub 2010 Feb 2.

Clinical Pharmacy, Atrium Medisch Centrum Parkstad, Heerlen, The Netherlands.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2817937PMC
February 2010
20 Reads
8 Citations
1.824 Impact Factor

The reason for discontinuation of the first tumor necrosis factor (TNF) blocking agent does not influence the effect of a second TNF blocking agent in patients with rheumatoid arthritis.

J Rheumatol 2009 Oct 1;36(10):2171-7. Epub 2009 Sep 1.

Department of Rheumatology, Radboud University Nijmegen Medical Centre, PO Box 9101, H 470, 6500 HB Nijmegen, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.090054DOI Listing
October 2009
16 Reads
8 Citations
3.190 Impact Factor

Borrelial fasciitis: as yet insufficient proof for a distinct entity.

Rheumatol Int 2009 Sep 9;29(11):1385-8. Epub 2009 Jun 9.

Department of Rheumatology, Medical Centre Leeuwarden, 8934 AD Leeuwarden, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00296-009-0987-3DOI Listing
September 2009
11 Reads
1.630 Impact Factor

An evidence-based assessment of the clinical significance of drug-drug interactions between disease-modifying antirheumatic drugs and non-antirheumatic drugs according to rheumatologists and pharmacists.

Clin Ther 2009 Aug;31(8):1737-46

Department of Pharmacotherapy and Pharmaceutical Care, University of Groningen, 9713 AV Groningen, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clinthera.2009.08.009DOI Listing
August 2009
18 Reads
2 Citations
2.731 Impact Factor

Gout--current diagnosis and treatment.

Dtsch Arztebl Int 2009 Aug 24;106(34-35):549-55. Epub 2009 Aug 24.

Bereich Rheumatologie, Medizinische Klinik und Poliklinik III, Universitätsklinikum, Carl Gustav Carus an der TU Dresden, Dresden, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3238/arztebl.2009.0549DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2754667PMC
August 2009
44 Reads
16 Citations
3.610 Impact Factor

A simple method for quantification of allopurinol and oxipurinol in human serum by high-performance liquid chromatography with UV-detection.

J Pharm Biomed Anal 2007 Oct 9;45(2):312-7. Epub 2007 Aug 9.

Department of Clinical Pharmacy and Pharmacology, Medisch Centrum Leeuwarden, Leeuwarden, The Netherlands.

View Article

Download full-text PDF

Source
http://www.rug.nl/research/portal/files/2773982/Reinders_200
Web Search
http://linkinghub.elsevier.com/retrieve/pii/S073170850700445
Publisher Site
http://dx.doi.org/10.1016/j.jpba.2007.08.002DOI Listing
October 2007
19 Reads
2 Citations
2.980 Impact Factor

Biochemical effectiveness of allopurinol and allopurinol-probenecid in previously benzbromarone-treated gout patients.

Clin Rheumatol 2007 Sep 17;26(9):1459-65. Epub 2007 Feb 17.

Department of Clinical Pharmacy and Pharmacology, Medical Centre Leeuwarden, Henri Dunantweg 2, 8934 AD, Leeuwarden, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10067-006-0528-3DOI Listing
September 2007
11 Reads
10 Citations
1.774 Impact Factor

Medical mystery: arthritis--the answer.

N Engl J Med 2006 Jul;355(4):421-2

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMc066303DOI Listing
July 2006
8 Reads
55.873 Impact Factor

Images in clinical medicine. A medical mystery--arthritis.

N Engl J Med 2006 Jun;354(22):2375

Medisch Centrum Leeuwarden, 8934 AD Leeuwarden, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMicm041004DOI Listing
June 2006
7 Reads
55.873 Impact Factor

Parenteral gold preparations. Efficacy and safety of therapy after switching from aurothioglucose to aurothiomalate.

J Rheumatol 2005 Jun;32(6):1026-30

Department of Clinical Pharmacy and Clinical Pharmacology, Medisch Centrum Leeuwarden, Leeuwarden, The Netherlands.

View Article

Download full-text PDF

Source
June 2005
20 Reads
3.190 Impact Factor

Leflunomide for the treatment of rheumatoid arthritis in clinical practice: incidence and severity of hepatotoxicity.

Drug Saf 2004 ;27(5):345-52

Department of Clinical Pharmacy and Clinical Pharmacology, Medical Centre Leeuwarden, Leeuwarden, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2165/00002018-200427050-00006DOI Listing
August 2004
15 Reads
7 Citations
2.824 Impact Factor

Diagnostic value of anticyclic citrullinated peptide antibody in rheumatoid arthritis.

J Rheumatol 2004 May;31(5):1012-3; author reply 1013

View Article

Download full-text PDF

Source
May 2004
13 Reads
3.190 Impact Factor

Top co-authors

William J Taylor
William J Taylor

University of Otago

13
Nicola Dalbeth
Nicola Dalbeth

University of Auckland

13
Jaap Fransen
Jaap Fransen

Radboud University Nijmegen Medical Centre

12
Matthijs Janssen
Matthijs Janssen

Rijnstate Hospital

12
Tuhina Neogi
Tuhina Neogi

Boston University School of Medicine

11
Anne-Kathrin Tausche
Anne-Kathrin Tausche

University Clinic Carl Gustav Carus

10
Lisa K Stamp
Lisa K Stamp

University of Otago

8